Journal Articles

RCT of treatments for pyoderma gangrenosum: time to get involved

Share this article

RCT of treatments for pyoderma gangrenosum: time to get involved

Eleanor Mitchell
8 November 2010

Background: Pyoderma gangrenosum (PG) is a rare, painful ulcerating skin condition that is often associated with underlying systemic disease such as inflammatory bowel disease, rheumatoid arthritis and haematological malignancies. There has been little research done into treatments for the disease. Aims: The STOP GAP trial will be the first trial to investigate the two most commonly used treatments for PG. The study aims to test the hypothesis that ciclosporin (Neoral®) is more effective than systemic prednisolone for the treatment of PG. One hundred and forty patients will be recruited by April 2012. Methods: Patients with a clinical diagnosis of PG are being recruited from around 50 dermatology departments in secondary care trusts in the UK. They are being randomised to either prednisolone (0.75 mg/kg/day) or ciclosporin (4 mg/kg/day). For cases where topical therapy is indicated, patients are being entered into a parallel observational study. Results: The study is ongoing and results should be published by August 2013. Conclusions: The STOP GAP trial is now the largest randomised controlled trial (RCT) ever conducted in PG and will provide clinicians with an evidence base for the treatment of this debilitating condition for the first time.

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.